Seeking Alpha

Revolution Medicines: Early-Stage Firm Whose High Valuation I Cannot Explain

Lead candidate RMC-4630 has trials running in NSCLC and various solid tumors. Earlier, it published data from a phase 1 trial, a dose escalation study in combination with Cobimetinib in Relapsed/ ...
The Globe and Mail

BeOne Medicines Advances Early Cancer Trial for BG-75098, Signaling Steady Pipeline Progress

BeOne Medicines is running an early-stage trial to test a new cancer drug, BG-75098, in adults with advanced solid tumors. The official title shows a Phase 1a/1b open-label study that aims to assess ...
Seeking Alpha

Sanofi to acquire Blueprint Medicines, expanding portfolio in rare immunological disease and adding early-stage pipeline in immunology

PARIS and CAMBRIDGE, Mass., June 2, 2025 /PRNewswire/ -- Sanofi and Blueprint Medicines Corporation (BPMC) (Blueprint), a US-based, publicly traded biopharmaceutical company specializing in systemic ...
STAT

Early data from rare-disease trial put spotlight on Moderna’s efforts to turn mRNA into medicines

LONDON — Moderna may be best known for its Covid-19 vaccine, but since its start, it’s always been set on developing therapies. On Wednesday, scientists reported interim results from an early study of ...
FierceBiotech

KEYTRUDA® (pembrolizumab) is First Medicine to be Made Available to Patients Through U.K. Early Access to Medicines Scheme (EAMS) for Advanced Melanoma

"We welcome the Government's proactive approach in facilitating early access to medicines for critically ill patients and are delighted that pembrolizumab will be the first innovative medicine to be ...